EResearch Posts Perspective on Microbix Biosystems Inc. - KMPH FOX 26 | Central San Joaquin Valley News Source

EResearch Posts Perspective on Microbix Biosystems Inc.

Posted: Updated:


Biosystems Inc. focuses on developing and commercializing biological products

and technologies through leveraging its Core Base Business of developing

infectious disease antigens (virology) for sale to large diagnostic kit


The Company has reported Q4 and full-year F2013

results, with revenue for F2013 up 14% compared with F2012. Microbix

has provided updates on its thrombolytic drug Kinlytic™ (Urokinase)

as well as announcing patent litigation against Novartis Vaccines and


Read more in the Perspective here: Microbix Biosystems


is a primary source for professional investment research, focused on small- and

mid-cap companies. Our research and analysis is of institutional quality, and

has the potential for reaching millions of global investors through our

extensive electronic distribution network.


posts all its reports and articles on its website,,

and subscription is FREE.


eResearch: Bob Weir, CFA,

Director of Research

(416) 703-6258


ReleaseID: 30446

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KMPH. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.